Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein

Andrew X. Zhu, Richard S. Finn, Peter R. Galle, Josep M. Llovet, Masatoshi Kudo

Research output: Contribution to journalLetterpeer-review

38 Scopus citations
Original languageEnglish
Pages (from-to)e191
JournalThe Lancet Oncology
Volume20
Issue number4
DOIs
StatePublished - Apr 2019

Cite this